Department of Radiology
Found 31 results
Filters: Author is Humm, John L  [Clear All Filters]
2023
Bodei L, R Tuttle M, Grewal RK, Mauguen A, Augensen F, Abusamra M, Mahajan S, Jayaprakasam VSudar, Osborne JR, Haque S et al..  2023.  Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs.. Eur J Nucl Med Mol Imaging.
Mauguen A, Grewal RK, Augensen F, Abusamra M, Mahajan S, Jayaprakasam VSudar, Osborne J, Haque S, Z Y Wong B, Ghossein RA et al..  2023.  The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients.. Eur J Nucl Med Mol Imaging. 50(10):2971-2983.
2021
Nehmeh SA, Moussa MB, Lee N, Zanzonico P, Gönen M, Humm JL, Schöder H.  2021.  Comparison of FDG and FMISO uptakes and distributions in head and neck squamous cell cancer tumors.. EJNMMI Res. 11(1):38.
Yerrabelli RS, He P, Fung EK, Kramer K, Zanzonico PB, Humm JL, Guo H, Pandit-Taskar N, Larson SM, Cheung N-KV.  2021.  IntraOmmaya compartmental radioimmunotherapy using I-omburtamab-pharmacokinetic modeling to optimize therapeutic index.. Eur J Nucl Med Mol Imaging. 48(4):1166-1177.
2019
Pandit-Taskar N, Zanzonico PB, Kramer K, Grkovski M, Fung EK, Shi W, Zhang Z, Lyashchenko SK, Fung AM, Pentlow KS et al..  2019.  Biodistribution and Dosimetry of Intraventricularly Administered I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors.. J Nucl Med. 60(12):1794-1801.
Carrasquillo JA, Fine BM, Pandit-Taskar N, Larson SM, Fleming SE, Fox JJ, Cheal SM, O'Donoghue JA, Ruan S, Ragupathi G et al..  2019.  Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using Zr-DFO-MSTP2109A Anti-STEAP1 Antibody.. J Nucl Med. 60(11):1517-1523.
O'Donoghue JA, Danila DC, Pandit-Taskar N, Beylergil V, Cheal SM, Fleming SE, Fox JJ, Ruan S, Zanzonico PB, Ragupathi G et al..  2019.  Pharmacokinetics and Biodistribution of a [Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients.. Mol Pharm. 16(7):3083-3090.
2018
Nehmeh SA, Schwartz J, Grkovski M, Yeung I, Laymon CM, Muzi M, Humm JL.  2018.  Inter-operator variability in compartmental kinetic analysis of F-fluoromisonidazole dynamic PET.. Clin Imaging. 49:121-127.
Fox JJ, Gavane SC, Blanc-Autran E, Nehmeh S, Gönen M, Beattie B, Vargas HA, Schöder H, Humm JL, Fine SW et al..  2018.  Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer.. JAMA Oncol. 4(2):217-224.
2017
Schwartz J, Grkovski M, Rimner A, Schöder H, Zanzonico PB, Carlin SD, Staton KD, Humm JL, Nehmeh SA.  2017.  Pharmacokinetic Analysis of Dynamic F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.. J Nucl Med. 58(6):911-919.
2016
Grkovski M, Schwartz J, Gönen M, Schöder H, Lee NY, Carlin SD, Zanzonico PB, Humm JL, Nehmeh SA.  2016.  Feasibility of 18F-Fluoromisonidazole Kinetic Modeling in Head and Neck Cancer Using Shortened Acquisition Times.. J Nucl Med. 57(3):334-41.
Grkovski M, Schwartz J, Rimner A, Schöder H, Carlin SD, Zanzonico PB, Humm JL, Nehmeh SA.  2016.  Reproducibility of F-fluoromisonidazole intratumour distribution in non-small cell lung cancer.. EJNMMI Res. 6(1):79.
2011
Fox JJ, Autran-Blanc E, Morris MJ, Gavane S, Nehmeh S, Van Nuffel A, Gönen M, Schöder H, Humm JL, Scher HI et al..  2011.  Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CT.. J Nucl Med. 52(11):1727-32.
2009
Wang W, Georgi J-C, Nehmeh SA, Narayanan M, Paulus T, Bal M, O'Donoghue J, Zanzonico PB, C Schmidtlein R, Lee NY et al..  2009.  Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging.. Phys Med Biol. 54(10):3083-99.
Wang K, Yorke E, Nehmeh SA, Humm JL, C Ling C.  2009.  Modeling acute and chronic hypoxia using serial images of 18F-FMISO PET.. Med Phys. 36(10):4400-8.
2008
Greco C, Nehmeh SA, Schöder H, Gönen M, Raphael B, Stambuk HE, Humm JL, Larson SM, Lee NY.  2008.  Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer.. Am J Clin Oncol. 31(5):439-45.
Lee NY, Mechalakos JG, Nehmeh S, Lin Z, Squire OD, Cai S, Chan K, Zanzonico PB, Greco C, Ling CC et al..  2008.  Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.. Int J Radiat Oncol Biol Phys. 70(1):2-13.
Nehmeh SA, Lee NY, Schröder H, Squire O, Zanzonico PB, Erdi YE, Greco C, Mageras G, Pham HS, Larson SM et al..  2008.  Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.. Int J Radiat Oncol Biol Phys. 70(1):235-42.
2007
Meirelles GSP, Erdi YEmre, Nehmeh SA, Squire OD, Larson SM, Humm JL, Schöder H.  2007.  Deep-inspiration breath-hold PET/CT: clinical findings with a new technique for detection and characterization of thoracic lesions.. J Nucl Med. 48(5):712-9.
Nehmeh SA, Erdi YE, Meirelles GSP, Squire O, Larson SM, Humm JL, Schöder H.  2007.  Deep-inspiration breath-hold PET/CT of the thorax.. J Nucl Med. 48(1):22-6.
2006
C Schmidtlein R, Kirov AS, Nehmeh SA, Erdi YE, Humm JL, Amols HI, Bidaut LM, Ganin A, Stearns CW, McDaniel DL et al..  2006.  Validation of GATE Monte Carlo simulations of the GE Advance/Discovery LS PET scanners.. Med Phys. 33(1):198-208.
2005
Pevsner A, Nehmeh SA, Humm JL, Mageras GS, Erdi YE.  2005.  Effect of motion on tracer activity determination in CT attenuation corrected PET images: A lung phantom study.. Med Phys. 32(7Part1):2358-2362.
Pevsner A, Nehmeh SA, Humm JL, Mageras GS, Erdi YE.  2005.  Effect of motion on tracer activity determination in CT attenuation corrected PET images: a lung phantom study.. Med Phys. 32(7):2358-62.
Larson SM, Nehmeh SA, Erdi YE, Humm JL.  2005.  PET/CT in non-small-cell lung cancer: value of respiratory-gated PET.. Chang Gung Med J. 28(5):306-14.
2004
Erdi YE, Nehmeh SA, Pan T, Pevsner A, Rosenzweig KE, Mageras G, Yorke ED, Schöder H, Hsiao W, Squire OD et al..  2004.  The CT motion quantitation of lung lesions and its impact on PET-measured SUVs.. J Nucl Med. 45(8):1287-92.